Ticker: MLYS

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) - quick read Snapshot - what's happening inside * Company is a clinical‑stage biotech focused on lorundrostat (aldosterone synthase inhibitor) across uncontrolled/resistant hypertension, CKD and obstructive sleep apnea. * Pivotal trials Launch‑HTN and ...